Profile: RENESA UG offers a complete system for Point of Care Testing for patients with suspected myocardial infarction. It consists of rapid tests, and an optional reader. Using the fast cardiac marker h-FABP, it facilitates an earlier diagnosis and, thus, helps to close the still existing diagnostic gap during the first hour of an infarction. We offer tests for two complementary cardio-specific proteins: h-FABP (heart specific Fatty Acid Binding Protein), and cTnI (cardiac Troponin I). h-FABP is an early cardiac-specific marker. It can be detected very early after onset of symptoms, and, thus allows early triaging of patients suspected of having an acute myocardial infarction. cTnI in contrast is a late marker. It takes more time to show up, but stays elevated much longer. The Troponins represent the classical gold standard for diagnosis of acute MI. We offer both markers separately, and together as a cardiac panel.

The company is CE Mark certified.